immune-mediated adverse events

/Tag:immune-mediated adverse events

HM2018 Abstract Number: 869

A CASE OF PEMBROLIZUMAB-INDUCED COMPLETE HEART BLOCK AND MYASTHENIA GRAVIS

Case Presentation: A 60-year-old man with coronary artery disease and metastatic renal cell carcinoma presents with worsening dyspnea on exertion 3 weeks after his first infusion of pembrolizumab. On presentation, he was tachycardic and in [...]

By | 2018-03-19T15:44:29+00:00 March 19th, 2018|Adult, Clinical Vignettes, Uncategorized|Comments Off on A CASE OF PEMBROLIZUMAB-INDUCED COMPLETE HEART BLOCK AND MYASTHENIA GRAVIS